GGrantIndex
Sort

11,323 grants matching glioblastoma

Targeting the Novel PI5P4K Pathway to Induce Glioblastoma Senescence

$337,450
Atsuo Sasaki · University Of Cincinnati · R01 · FY2018 · NS

Blood-brain barrier disruption with implantable ultrasound to enhance paclitaxel delivery: A Phase 1-2 clinical trial in recurrent glioblastoma

$337,354
Adam M Sonabend · Northwestern University At Chicago · R01 · FY2024 · CA

Spatio-temporal regulation of ARF signaling in vesicle formation

$337,264
Elizabeth S Sztul · University Of Alabama At Birmingham · R01 · FY2019 · GM

Targeting Glioblastoma Cells and Tumor Microenvironment with CAR-T Cell Therapy

$337,209
Yvonne Yu-Hsuan Chen · University Of California Los Angeles · P50 · FY2024 · CA

Using Proton MRS to Predict Response of SAHA treatment in Glioblastoma

$337,125
Hyunsuk Shim · Emory University · R21 · FY2010 · CA

Quantitative bioluminescence tomography for pre-clinical radiotherapy

$337,115
Ken Kang-Hsin Wang · Ut Southwestern Medical Center · R01 · FY2022 · CA

Contributions of Akt to Glioblastoma Formation

$337,088
University Of California San Francisco · R01 · FY2005 · CA

Contributions of Akt to Glioblastoma Formation

$337,088
University Of California San Francisco · R01 · FY2004 · CA

Role of mTORC2 in GBM - development of a novel therapeutic mTOR kinase inhibitor

$337,006
Paul S Mischel · Ludwig Institute For Cancer Res Ltd · R01 · FY2013 · NS

Targeting the Fn14-Rac1 signaling pathway in invasive gliomas

$336,935
Nhan L Tran · Translational Genomics Research Inst · R01 · FY2012 · CA

Improving extent of glioblastoma resection by combining volumetric MRSI and 5-ALA

$336,932
Hyunsuk Shim · Emory University · R21 · FY2014 · CA

Transcriptional control of OPC fate specification and homing to gray matter and white matter in the CNS

$336,929
Tou Yia Vue · University Of New Mexico Health Scis Ctr · R01 · FY2025 · NS

Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma

$336,875
Clark Chin-Chung Chen · University Of Minnesota · R01 · FY2019 · NS

Analysis of alphaVbeta8 Integrin In Gliomagenesis

$336,875
Joseph H McCarty · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · NS

Neural Progenitor Genes and Brain Tumors

$336,875
Harley I Kornblum · University Of California Los Angeles · R01 · FY2012 · NS

OV therapy induced changes in tumor secretome and their impact on therapy

$336,875
Balveen Kaur · Ohio State University · R01 · FY2016 · NS

Neural Progenitor Genes and Brain Tumors

$336,875
Harley I Kornblum · University Of California Los Angeles · R01 · FY2011 · NS

Targeting the cholesterol metabolism to treat glioblastoma

$336,875
Deliang Guo · Ohio State University · R01 · FY2017 · NS

Analysis of alphaVbeta8 Integrin In Gliomagenesis

$336,875
Joseph H McCarty · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · NS

OV therapy induced changes in tumor secretome and their impact on therapy

$336,875
Balveen Kaur · University Of Texas Hlth Sci Ctr Houston · R01 · FY2017 · NS

Targeting the cholesterol metabolism to treat glioblastoma

$336,875
Deliang Guo · Ohio State University · R01 · FY2015 · NS

Neural Progenitor Genes and Brain Tumors

$336,875
Harley I Kornblum · University Of California Los Angeles · R01 · FY2015 · NS

Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma

$336,875
Clark Chin-Chung Chen · University Of Minnesota · R01 · FY2021 · NS

Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma

$336,875
Clark Chin-Chung Chen · University Of Minnesota · R01 · FY2020 · NS

OV therapy induced changes in tumor secretome and their impact on therapy

$336,875
Balveen Kaur · Ohio State University · R01 · FY2015 · NS